Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Halide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1191230C details a safe magnesium-catalyzed route for neuraminidase inhibitors, offering significant supply chain safety and cost advantages for pharmaceutical manufacturers.
Patent CN112778252A reveals a novel N-doped carbon bimetallic catalyst for converting o-xylene to phthalide with high selectivity, offering safer and cost-effective production.
Novel formic acid solvent method boosts yield for coptisine halide salt production ensuring cost efficiency and supply reliability for pharmaceutical partners.
Patent CN1331686A details a novel dehydration route for 5-cyanophthalide, offering superior yields and eliminating heavy metal catalysts for cost-effective API manufacturing.
Novel THF-based Grignard route ensures scalable production of anti-ischemia drug intermediates. Eliminates column chromatography for cost-effective supply chain solutions and high purity standards.
Patent CN102250076A reveals a mild, high-yield route for Rivaroxaban intermediates using magnesium halides, offering significant cost reduction and supply chain reliability for API manufacturers.
Novel alkali metal halide catalyzed method ensures stable quality and high yield for hydrocortisone acetate manufacturing supply chain efficiency.
Patent CN110563696B reveals a robust method for heteroatom-containing cyclohexene halides, offering significant cost reduction and simplified purification for fine chemical manufacturing.
Novel catalytic route for high-purity fluoroquinolone intermediates. Reduces alkali usage and boosts yield to 82.5% via one-pot synthesis.
Patent CN115010563B reveals a green nickel-catalyzed halogen exchange method. This technology offers cost reduction in pharmaceutical intermediate manufacturing via mild visible light conditions.
Patent CN102070586A introduces a mild hydrazone-based route for 4-heteroatom cyclohexenyl halides. Avoids cryogenic temps, ensures >97% purity, scalable for API manufacturing.
Patent CN1323293A details a high-yield regioselective synthesis of N-substituted hydroxycycloalkylamines using 1,2-cyclosulfinyl alkyl halides, offering significant cost reduction in API manufacturing.
Patent CN107325002A details a green silver-catalyzed decarboxylative halogenation route. This method offers cost reduction in pharma intermediate manufacturing and enhanced supply chain reliability.
Novel aryl halide synthesis via cyclization offers high purity and yield. Reliable supplier for pharmaceutical intermediates ensuring cost reduction and supply continuity.
Patent CN112573978A reveals a high-yield sulfoxide-catalyzed halogenation method offering significant cost reduction and safety improvements for pharmaceutical intermediate manufacturing.
Advanced Raney Nickel catalyzed synthesis of butylphthalide eliminates high-energy rectification. Delivers >99% purity for reliable API intermediate supply chains.
Patent CN114478290A reveals a metal halide catalyzed route for oseltamivir intermediates, offering superior purity and yield without column chromatography for reliable supply chains.
Patent CN107325002B details a green Ag/Cu-catalyzed decarboxylative halogenation method. It offers cost reduction in pharmaceutical intermediate manufacturing using cheap halide salts.
Patent CN115925722B details a scalable copper halide method for tazobactam intermediates. This process offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel patent CN108623456A offers mild conditions for butylphthalide. Reduces cost and improves safety for reliable pharmaceutical intermediate supplier.